Sensus Healthcare Inc. Insider Trading

SRTS

⊜ Compare

Last 12 months

Insiders bought 728K on the open market and sold nothing.

Net open-market

+728K

12 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

3 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 31, 2026

Get an email when SRTS's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 28 – 31	Eric Sachetta Director	Bought 2 parts	64,841	$3.48 average	226K	28%	Form 4
Aug 26 – 27	Eric Sachetta Director	Bought 2 parts	20,633	$3.23 average	67K	9.8%	Form 4
Aug 24	Eric Sachetta Director	Bought	34,697	$3.25	113K	20%	Form 4
Aug 20 – 21	Eric Sachetta Director	Bought 2 parts	31,000	$3.16 average	98K	21%	Form 4
Aug 20	Joseph C Sardano Chief Executive Officer	Bought	20,000	$3.02	60K	1.7%	Form 4
May 12	Eric Sachetta Director	Bought	1,500	$3.34	5K	1.0%	Form 4
Feb 24	Eric Sachetta Director	Bought	2,000	$3.81	8K	1.4%	Form 4
Nov 21, 2025	Eric Sachetta Director	Bought	7,000	$3.93	28K	5.3%	Form 4
Nov 18, 2025	Michael Sardano President and General Counsel	Bought	1,000	$3.80	4K	0.8%	Form 4
Nov 18, 2025	Joseph C Sardano Chief Executive Officer	Bought	25,000	$4.03	101K	2.1%	Form 4
Nov 13, 2025	Eric Sachetta Director	Bought	2,500	$4.50	11K	1.9%	Form 4
Nov 11, 2025	Michael Sardano President and General Counsel	Bought 3 parts	2,000	$4.27 average	9K	1.7%	Form 4
Aug 13, 2025	Michael Sardano President and General Counsel	Bought	1,000	$3.37	3K	0.9%	Form 4
Feb 10, 2025	Javier Rampolla Chief Financial Officer	Bought	501	$5.95	3K	1.2%	Form 4
Feb 10, 2025	Michael Sardano President and General Counsel	Bought	1,000	$5.95	6K	0.9%	Form 4

Aug 28 – 31
Eric Sachetta
Director · bought 64,841 at avg $3.48
226K
28% of stake
Aug 26 – 27
Eric Sachetta
Director · bought 20,633 at avg $3.23
67K
9.8% of stake
Aug 24
Eric Sachetta
Director · bought 34,697 at $3.25
113K
20% of stake
Aug 20 – 21
Eric Sachetta
Director · bought 31,000 at avg $3.16
98K
21% of stake
Aug 20
Joseph C Sardano
Chief Executive Officer · bought 20,000 at $3.02
60K
1.7% of stake
May 12
Eric Sachetta
Director · bought 1,500 at $3.34
5K
1.0% of stake
Feb 24
Eric Sachetta
Director · bought 2,000 at $3.81
8K
1.4% of stake
Nov 21, 2025
Eric Sachetta
Director · bought 7,000 at $3.93
28K
5.3% of stake
Nov 18, 2025
Michael Sardano
President and General Counsel · bought 1,000 at $3.80
4K
0.8% of stake
Nov 18, 2025
Joseph C Sardano
Chief Executive Officer · bought 25,000 at $4.03
101K
2.1% of stake
Nov 13, 2025
Eric Sachetta
Director · bought 2,500 at $4.50
11K
1.9% of stake
Nov 11, 2025
Michael Sardano
President and General Counsel · bought 2,000 at avg $4.27
9K
1.7% of stake
Aug 13, 2025
Michael Sardano
President and General Counsel · bought 1,000 at $3.37
3K
0.9% of stake
Feb 10, 2025
Javier Rampolla
Chief Financial Officer · bought 501 at $5.95
3K
1.2% of stake
Feb 10, 2025
Michael Sardano
President and General Counsel · bought 1,000 at $5.95
6K
0.9% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch SRTS, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with SRTS

CompareIntrinsic value

BTCYBiotricity Inc.

$0.06+1.29%64

PROFProfound Medical Corp.

$7.16+2.43%50

SNOASonoma Pharmaceuticals Inc.

$1.11-2.63%40

MDAISpectral AI Inc.

$1.53+2.00%10

NEPHNephros Inc.

$3.25+0.31%54

VVOSVivos Therapeutics, Inc.

$0.11+0.91%26

DRIODarioHealth Corp.

$2.97-1.00%25

ALURAllurion Technologies Inc.

$0.02+0.00%10

Held by ETFs

SRTS is in 1 US ETF. The largest of them, with SRTS's weight in each:

Dimensional US Small Cap Value ETFDFSV0.00%of the fund

Spot a number that looks wrong? Check it in SRTS's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing SRTS

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.